ANI Pharmaceuticals, Inc. (ANIP) stock analysis

ANIP · ANI Pharmaceuticals, Inc.

Latest recorded price: USD 70.89

Model-estimated fair value: USD 157.81. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Drug Manufacturers - Specialty & Generic

At $70.89, ANIP trades 55.1% below the model's base-case value of $157.81. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $120.07 in the conservative case and $203.25 in the optimistic case, with a valuation confidence score of 55/100. Fiscal 2025 figures: revenue growth 40.8%, free cash flow margin 19.4%, ROIC 21.0%. The model does not flag any risk signals for this company.

Similar companies in Healthcare